Resources
52 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 3/10/2024 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration's (SAMHSA) updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. It emphasizes harm reduction and access to treatment as essential aspects of overdose prevention.
Posted 12/15/2023 (updated 3/28/2024)
The Opioid-Overdose Reduction Continuum of Care Approach is a guide for policymakers for implementing evidence-based strategies that address opioid overdose.
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 5/30/2023 (updated 3/27/2024)
Overdose Detection Mapping and Application Program (ODMAP) is a free, web-based, overdose reporting platform. It is for local, state, federal, and tribal public safety and public health entities working in overdose response, reduction, and prevention.
Posted 4/5/2023 (updated 3/27/2024)
The Northwest Prevention Technology Transfer Center (PTTC) Network has developed an Alcohol Awareness Toolkit to use during Alcohol Awareness Month. The Alcohol Awareness Toolkit will help you raise awareness about alcohol-related harms and the importance of strong alcohol policies. It also encourages engagement from prevention and public health stakeholders to strategically educate and inform decision-makers about effective alcohol policies by providing easy-to-personalize, templated opinion editorials, letters to legislators, and proclamations.
Posted 4/4/2023 (updated 3/27/2024)
The U.S. Food and Drug Administration (FDA) announced that the makers of Narcan, an opioid overdose treatment, have the agency’s approval to make the drug widely available over the counter (OTC). Narcan is the brand name of the drug naloxone, a fast-acting overdose reversal. Until now, availability varied by state – typically restricted to licensed health care providers, approved opioid overdose programs, and first responders. This is an important consideration for rural counties given that research shows that these areas are nearly three times more likely than metropolitan counties to be a low-dispensing county for naloxone.
Posted 2/7/2023 (updated 3/27/2024)
The National Council for Mental Wellbeing announced a toolkit, Public Safety-led Community-oriented Overdose Prevention Efforts (PS-COPE), which provides framework to use to enhance overdose prevention and response in the Black, Indigenous and people of color (BIPOC) communities. The toolkit provides tips, tools, and resources to help integrate this approach into existing overdose prevention and response efforts.
Posted 12/13/2022 (updated 3/27/2024)
Posted 11/15/2022 (updated 3/27/2024)
In this decision analytical model study evaluating the distribution of 10 000 additional naloxone kits annually in Rhode Island, the strategy focusing on distribution of naloxone according to geographic need to people who inject drugs resulted in the best outcomes at the lowest cost, averting an estimated 25.3% of opioid overdose deaths at an incremental cost of $27 312 per opioid overdose death averted
Posted 11/1/2022 (updated 3/27/2024)